Trial · NCT07899541
AI-Assisted Child Health Podcast Education for Nursing Students
NCT07899541, Not applicable, Active not recruiting, Izmir University of Economics
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. AI-Assisted Child Health Podcast Education for Nursing Students. Trials, record NCT07899541. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07899541
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- AI-Assisted Child Health Podcast Education for Nursing Students
- NCT number
- NCT07899541
- Status
- Active not recruiting
- Phases
- Not applicable
- Enrollment
- 23 participants, estimated
- Lead sponsor
- Izmir University of Economics
- Conditions
- Nursing Education
- Interventions
- AI-Assisted Child Health Podcast Development and Implementation
- First posted
- 2026-10-27
- Last updated
- 2026-10-27
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Attitudes Toward Clinical Practice | Baseline (T0), 5 weeks after baseline (T1), and 10 weeks after baseline (T2). | Attitudes toward clinical practice will be assessed using the Attitude Scale Toward Clinical Practice for Nursing Students. The scale consists of 26 items rated on a 5-point Likert scale. Total scores range from 26 to 130, with higher scores indicating more positive attitudes toward clinical practice. Changes over time and differences between the early intervention and delayed intervention/wait-list control groups will be evaluated. |
| Primary | Change in Learning Goal Orientation | Baseline (T0), 5 weeks after baseline (T1), and 10 weeks after baseline (T2). | Learning goal orientation will be assessed using the Learning Goals subscale of the Motivation for Learning in Higher Education Scale (EMAPRE-U). The subscale consists of 8 items rated on a 3-point Likert scale, with scores ranging from 8 to 24. Higher scores indicate a stronger orientation toward learning, acquiring knowledge, and personal development. Changes over time and differences between study groups will be evaluated. |
| Secondary | Change in Performance-Approach Goal Orientation | Baseline (T0), 5 weeks after baseline (T1), and 10 weeks after baseline (T2). | Performance-approach goal orientation will be assessed using the Performance-Approach Goals subscale of the Motivation for Learning in Higher Education Scale (EMAPRE-U). The subscale consists of 8 items rated on a 3-point Likert scale, with scores ranging from 8 to 24. Higher scores indicate a stronger orientation toward demonstrating better performance than others. |
| Secondary | Change in Performance-Avoidance Goal Orientation | Baseline (T0), 5 weeks after baseline (T1), and 10 weeks after baseline (T2). | Performance-avoidance goal orientation will be assessed using the Performance-Avoidance Goals subscale of the Motivation for Learning in Higher Education Scale (EMAPRE-U). The subscale consists of 7 items rated on a 3-point Likert scale, with scores ranging from 7 to 21. Higher scores indicate a stronger tendency to avoid appearing unsuccessful or less competent than others. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07899541
GET https://conductscience.org/api/trials/v1/NCT07899541/registered